{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T23:08:57Z","timestamp":1769123337504,"version":"3.49.0"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"Supplement_M","license":[{"start":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T00:00:00Z","timestamp":1577750400000},"content-version":"vor","delay-in-days":30,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"National Science Centre","doi-asserted-by":"publisher","award":["2014\/13\/B\/NZ5\/03146"],"award-info":[{"award-number":["2014\/13\/B\/NZ5\/03146"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009687","name":"Wroclaw Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009687","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006484","name":"Vifor Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The 2016 ESC\/HFA heart failure (HF) guidelines emphasize the importance of identifying and treating iron deficiency (ID) in patients with HF. Iron deficiency can occur in half or more of HF sufferers, depending on age and the phase of the disease. Iron deficiency can be a cause of anaemia, but it is also common even without anaemia, meaning that ID is a separate entity, which should be screened for within the HF population. Although assessment of iron stores in bone marrow samples is the most accurate method to investigate iron status, it is not practical in most HF patients. Levels of circulating iron biomarkers are an easily available alternative; especially, ferritin and transferrin saturation (Tsat). In patients with HF serum ferritin level &amp;lt;100\u2009\u00b5g\/L (regardless of Tsat value) or between 100 and 299\u2009\u00b5g\/L with Tsat &amp;lt;20% are considered as recommended criteria for the diagnosis of ID, criteria which have been used in the clinical trials in HF that have led to a recommendation to treat ID with intravenous iron. We discuss the optimal measures of iron biomarkers in patients with HF in order to screen and monitor iron status and introduce some novel ways to assess iron status.<\/jats:p>","DOI":"10.1093\/eurheartj\/suz231","type":"journal-article","created":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T09:18:10Z","timestamp":1577783890000},"page":"M32-M35","source":"Crossref","is-referenced-by-count":13,"title":["Monitoring of iron status in patients with heart failure"],"prefix":"10.1093","volume":"21","author":[{"given":"Ewa A","family":"Jankowska","sequence":"first","affiliation":[{"name":"Department of Heart Diseases, Wroclaw Medical University, Borowska 213, 50-556 Wroclaw, Poland"},{"name":"Centre for Heart Diseases, University Hospital, Borowska 213, 50-556 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micha\u0142","family":"Tkaczyszyn","sequence":"additional","affiliation":[{"name":"Department of Heart Diseases, Wroclaw Medical University, Borowska 213, 50-556 Wroclaw, Poland"},{"name":"Centre for Heart Diseases, University Hospital, Borowska 213, 50-556 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcin","family":"Drozd","sequence":"additional","affiliation":[{"name":"Department of Heart Diseases, Wroclaw Medical University, Borowska 213, 50-556 Wroclaw, Poland"},{"name":"Centre for Heart Diseases, University Hospital, Borowska 213, 50-556 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Ponikowski","sequence":"additional","affiliation":[{"name":"Department of Heart Diseases, Wroclaw Medical University, Borowska 213, 50-556 Wroclaw, Poland"},{"name":"Centre for Heart Diseases, University Hospital, Borowska 213, 50-556 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,12,31]]},"reference":[{"key":"2019123104175555400_suz231-B1","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2019123104175555400_suz231-B2","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/ejhf.1202","article-title":"Prevalence and prognostic impact of non-cardiac co-morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community-based study","volume":"20","author":"Iorio","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2019123104175555400_suz231-B3","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/ejhf.473","article-title":"Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: a meta-analysis of randomized controlled trials","volume":"18","author":"Jankowska","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2019123104175555400_suz231-B4","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s40256-016-0211-2","article-title":"Iron therapy in patients with heart failure and iron deficiency: review of iron preparations for practitioners","volume":"17","author":"Drozd","year":"2017","journal-title":"Am J Cardiovasc Drugs"},{"key":"2019123104175555400_suz231-B5","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ahj.2013.01.017","article-title":"Iron deficiency in chronic heart failure: an international pooled analysis","volume":"165","author":"Klip","year":"2013","journal-title":"Am Heart J"},{"key":"2019123104175555400_suz231-B6","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/ejhf.139","article-title":"High prevalence of iron deficiency in patients with acute decompensated heart failure","volume":"16","author":"Cohen-Solal","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"2019123104175555400_suz231-B7","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N Engl J Med"},{"key":"2019123104175555400_suz231-B8","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","article-title":"Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency","volume":"36","author":"Ponikowski","year":"2015","journal-title":"Eur Heart J"},{"key":"2019123104175555400_suz231-B9","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1161\/CIRCULATIONAHA.117.027497","article-title":"Effect of ferric carboxymaltose on exercise capacity in patients with chronic heart failure and iron deficiency","volume":"136","author":"Van Veldhuisen","year":"2017","journal-title":"Circulation"},{"key":"2019123104175555400_suz231-B10","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.cjca.2015.06.009","article-title":"The efficacy and safety of iron supplementation in patients with heart failure and iron deficiency: a systematic review and meta-analysis","volume":"32","author":"Qian","year":"2016","journal-title":"Can J Cardiol"},{"key":"2019123104175555400_suz231-B11","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/jcsm.12282","article-title":"Depleted iron stores are associated with inspiratory muscle weakness independently of skeletal muscle mass in men with systolic chronic heart failure","volume":"9","author":"Tkaczyszyn","year":"2018","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2019123104175555400_suz231-B12","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/ejhf.467","article-title":"The influence of iron deficiency on the functioning of skeletal muscles: experimental evidence and clinical implications","volume":"18","author":"Stugiewicz","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2019123104175555400_suz231-B13","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/eurheartj\/ehs224","article-title":"Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives","volume":"34","author":"Jankowska","year":"2013","journal-title":"Eur Heart J"},{"key":"2019123104175555400_suz231-B14","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/ejhf.1154","article-title":"Iron deficiency impairs contractility of human cardiomyocytes through decreased mitochondrial function","volume":"20","author":"Hoes","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2019123104175555400_suz231-B15","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1002\/ejhf.1311","article-title":"Impact of exercise-based cardiac rehabilitation in patients with heart failure (ExTraMATCH II) on mortality and hospitalisation: an individual patient data meta-analysis of randomised trials","volume":"20","author":"Taylor","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2019123104175555400_suz231-B16","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1002\/ejhf.1304","article-title":"Comparison of sarcopenia and cachexia in men with chronic heart failure: results from the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF)","volume":"20","author":"Emami","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2019123104175555400_suz231-B17","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1002\/ejhf.918","article-title":"The muscle hypothesis revisited","volume":"19","author":"Stewart Coats","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2019123104175555400_suz231-B18","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/ehf2.12333","article-title":"Iron deficiency in chronic heart failure: case-based practical guidance","volume":"5","author":"Lam","year":"2018","journal-title":"ESC Heart Fail"},{"key":"2019123104175555400_suz231-B19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.15420\/cfr.2018:6:2","article-title":"Iron therapy in heart failure: ready for primetime?","volume":"4","author":"Mordi","year":"2018","journal-title":"Card Fail Rev"},{"key":"2019123104175555400_suz231-B20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.15420\/cfr.2018:8:2","article-title":"Pharmacological interventions effective in improving exercise capacity in heart failure","volume":"4","author":"Vitale","year":"2018","journal-title":"Card Fail Rev"},{"key":"2019123104175555400_suz231-B21","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/jcsm.12314","article-title":"Iron deficiency as energetic insult to skeletal muscle in chronic diseases","volume":"9","author":"Dziegala","year":"2018","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2019123104175555400_suz231-B22","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.3748\/wjg.15.4627","article-title":"Classification of anemia for gastroenterologists","volume":"15","author":"Moreno Chulilla","year":"2009","journal-title":"World J Gastroenterol"},{"key":"2019123104175555400_suz231-B23","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1136\/gut.2010.228874","article-title":"Guidelines for the management of iron deficiency anaemia","volume":"60","author":"Goddard","year":"2011","journal-title":"Gut"},{"key":"2019123104175555400_suz231-B24","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1172\/JCI104793","article-title":"The quantitative estimation of total iron stores in human bone marrow","volume":"42","author":"Gale","year":"1963","journal-title":"J Clin Invest"},{"key":"2019123104175555400_suz231-B25","doi-asserted-by":"crossref","first-page":"525","DOI":"10.5694\/j.1326-5377.2010.tb04038.x","article-title":"Diagnosis and management of iron deficiency anaemia: a clinical update","volume":"193","author":"Pasricha","year":"2010","journal-title":"Med J Aust"},{"key":"2019123104175555400_suz231-B26","doi-asserted-by":"crossref","first-page":"4754","DOI":"10.1182\/blood-2010-05-286260","article-title":"Detection, evaluation, and management of iron-restricted erythropoiesis","volume":"116","author":"Goodnough","year":"2010","journal-title":"Blood"},{"key":"2019123104175555400_suz231-B27","first-page":"295","volume-title":"Williams Hematology","author":"Fairbanks","year":"2001"},{"key":"2019123104175555400_suz231-B28","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1093\/jn\/135.8.1974","article-title":"Hemoglobin and ferritin are currently the most efficient indicators of population response to iron interventions: an analysis of nine randomized controlled trials","volume":"135","author":"Mei","year":"2005","journal-title":"J Nutr"},{"key":"2019123104175555400_suz231-B29","first-page":"345","article-title":"Soluble transferrin receptors and iron deficiency, a step beyond ferritin. A systematic review","volume":"18","author":"Koulaouzidis","year":"2009","journal-title":"J Gastrointestin Liver Dis"},{"key":"2019123104175555400_suz231-B30","first-page":"945","article-title":"Serum ferritin concentration and bone marrow iron stores: a prospective study","volume":"118","author":"Ali","year":"1978","journal-title":"Can Med Assoc J"},{"key":"2019123104175555400_suz231-B31"},{"key":"2019123104175555400_suz231-B32","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/ajh.20249","article-title":"Iron deficiency: a concise review","volume":"78","author":"Umbreit","year":"2005","journal-title":"Am J Hematol"},{"key":"2019123104175555400_suz231-B33","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3324\/haematol.11705","article-title":"Hepcidin: from discovery to differential diagnosis","volume":"93","author":"Kemna","year":"2008","journal-title":"Haematologica"},{"key":"2019123104175555400_suz231-B34","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s10741-008-9086-x","article-title":"Iron and anemia in human biology: a review of mechanisms","volume":"13","author":"Handelman","year":"2008","journal-title":"Heart Fail. Rev"},{"key":"2019123104175555400_suz231-B35","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000243791","article-title":"The role of hepcidin in iron metabolism","volume":"122","author":"Nemeth","year":"2009","journal-title":"Acta Haematol"},{"key":"2019123104175555400_suz231-B36","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.cca.2010.07.003","article-title":"Hepcidin and iron metabolism: from laboratory to clinical implications","volume":"411","author":"Franchini","year":"2010","journal-title":"Clin Chim Acta"},{"key":"2019123104175555400_suz231-B37","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.biochi.2009.06.012","article-title":"Hepcidin, the iron watcher","volume":"91","author":"Viatte","year":"2009","journal-title":"Biochimie"},{"key":"2019123104175555400_suz231-B38","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/j.ajkd.2009.12.030","article-title":"Molecular mechanisms of hepcidin regulation: implications for the anemia of CKD","volume":"55","author":"Babitt","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"2019123104175555400_suz231-B39","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.2215\/CJN.01490506","article-title":"Assessing iron status: beyond serum ferritin and transferrin saturation","volume":"1","author":"Wish","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"2019123104175555400_suz231-B40","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1751-553X.2009.01160.x","article-title":"Quality counts: new parameters in blood cell counting","volume":"31","author":"Briggs","year":"2009","journal-title":"Int J Lab Hematol"},{"key":"2019123104175555400_suz231-B41","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1093\/eurheartj\/ehu235","article-title":"Iron deficiency defined as depleted iron stores accompanied by unmet cellular iron requirements identifies patients at the highest risk of death after an episode of acute heart failure","volume":"35","author":"Jankowska","year":"2014","journal-title":"Eur Heart J"},{"key":"2019123104175555400_suz231-B42","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.beha.2004.08.022","article-title":"Diagnosis and management of iron-deficiency anaemia","volume":"18","author":"Cook","year":"2005","journal-title":"Best Pract Res Clin Haematol"},{"key":"2019123104175555400_suz231-B43","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/eurheartj\/ehs377","article-title":"Iron status in patients with chronic heart failure","volume":"34","author":"Jankowska","year":"2013","journal-title":"Eur Heart J"},{"key":"2019123104175555400_suz231-B44","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1093\/eurjhf\/hfp140","article-title":"Rationale and design of Ferinject assessment in patients with IRon deficiency and chronic Heart Failure (FAIR-HF) study: a randomized, placebo-controlled study of intravenous iron supplementation in patients with and without anaemia","volume":"11","author":"Anker","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"2019123104175555400_suz231-B45","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/ejhf.820","article-title":"Iron deficiency and red cell indices in patients with heart failure","volume":"20","author":"Tkaczyszyn","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2019123104175555400_suz231-B46","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1002\/ejhf.1305","article-title":"Screening, diagnosis and treatment of iron deficiency in chronic heart failure: putting the 2016 European Society of Cardiology heart failure guidelines into clinical practice","volume":"20","author":"McDonagh","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2019123104175555400_suz231-B47","doi-asserted-by":"crossref","first-page":"84","DOI":"10.17987\/icfj.v10i0.440","article-title":"The management of co-morbidities in patients with heart failure\u2014iron deficiency","volume":"10","author":"Von Haehling","year":"2017","journal-title":"Int Cardiovasc Forum J"},{"key":"2019123104175555400_suz231-B48","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/ejhf.1174","article-title":"Cardiac iron deficiency\u2014how to refuel the engine out of fuel","volume":"20","author":"Martens","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2019123104175555400_suz231-B49","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/ejhf.967","article-title":"Iron status measurement in routine heart failure assessment: a call for action","volume":"20","author":"N\u00fa\u00f1ez","year":"2018","journal-title":"Eur J Heart Fail"}],"container-title":["European Heart Journal Supplements"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurheartjsupp\/article-pdf\/21\/Supplement_M\/M32\/31661503\/suz231.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/eurheartjsupp\/article-pdf\/21\/Supplement_M\/M32\/31661503\/suz231.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T09:18:21Z","timestamp":1577783901000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/article\/21\/Supplement_M\/M32\/5691324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,1]]},"references-count":49,"journal-issue":{"issue":"Supplement_M","published-online":{"date-parts":[[2019,12,31]]},"published-print":{"date-parts":[[2019,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/suz231","relation":{},"ISSN":["1520-765X","1554-2815"],"issn-type":[{"value":"1520-765X","type":"print"},{"value":"1554-2815","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,12]]},"published":{"date-parts":[[2019,12,1]]}}}